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Interventional radiology procedures are increasingly in demand in both the adult and pediatric populations. Pediatric procedures mirror
many of the adult procedures but with increased complexity due to many considerations, notably patient size. This article reviews the various
vascular pediatric interventional procedures. The aim is to provide a greater exposure to the possible treatment options for pediatric patients
and to facilitate understanding of the success and complications rates related to various interventions.Resume
La demande de procedures de radiologie d’intervention ne cesse de cro^ıtre chez les patients adultes et pediatriques. Les actes pediatriques
sont analogues a ceux pratiques chez les adultes, mais ils presentent une complexite accrue en raison de facteurs lies a la taille du patient.
L’article passe en revue les diverses procedures en radiopediatrie vasculaire. Il vise a mieux faire conna^ıtre les choix de traitement possibles
des patients pediatriques et a faciliter l’interpretation des taux de reussite et de complications lies a l’imagerie apres plusieurs interventions.
 2012 Canadian Association of Radiologists. All rights reserved.
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imaging and therapeutic intervention for a wide range of
medical conditions. In the pediatric population, a large
proportion of intervention involves obtaining mid- to long-
term vascular access. This procedure, relatively simple in
the adult population, becomes progressively more complex
as patient size decreases in the pediatric setting. Transarterial
procedures have many of the same indications as in the adult
population, such as embolization of arterial hemorrhage.
However, awareness of pediatric nuances is needed, such as
the workup of renovascular hypertension. Treatment of
congenital pathologies, such as low- and high-flow vascular
malformations, can be performed in childhood, thereby
reducing symptoms and the psychological stigma related to
them. This review will cover various vascular pediatric
interventional radiology procedures performed in a specialistDisclosures: The authors have no conflicts of interest to disclose.
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doi:10.1016/j.carj.2011.12.004pediatric centre. The important issues of sedation, coagul-
opathy, and radiation protection have been covered in the
sister article to this on nonvascular pediatric interventional
radiology.
Central Venous Access
Pediatric indications for central venous access include the
need for total parenteral nutrition; hemodialysis; adminis-
tration of certain medications, including chemotherapy,
prolonged intravenous antibiotics; and phlebotomy [1]. The
incidence of peripheral and central venous thrombosis and
infection increases with catheter size, insertion site, number
of lumens, tip position, duration in situ, and infusion type
[2e5]. These factors should be optimized by using the
smallest catheter for the shortest time, placed in the optimal
position. Temporary venous catheters can be inserted under
ultrasound guidance by many sites, including the femoral,
jugular, saphenous, and upper-arm venous circulation.
Coagulation parameters should be checked in any patient at
risk of a coagulopathy before the insertion of any jugular
venous catheter.ll rights reserved.
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good intermediate-term venous access, typically for
a period of several weeks. There are various types of
PICCs, with different French diameters and number
of lumens. The 3F or 4F catheters are reasonable for
most pediatric patients. The PowerPICC (Bard Access
Systems, Salt Lake City, UT) is designed to allow power
injection for contrast-enhanced computed tomography (CT)
imaging.
PICCs are ideally positioned in the nondependent arm,
often with the basilic vein as the primary site for access.
The cutaneous access point should be above the elbow to
facilitate comfortable elbow movement and avoid kinking.
The tip of the PICC ideally should be at the right atrial-
caval junction, which is just below the inferior edge of
the right main stem bronchus or the sixth posterior inter-
costal space [1,6]. In young children, the PICC tip can
be move, depending on arm position, and this should be
assessed at the time of insertion (Figure 1). A catheter
situated within the right atrium can result in several
complications, including fatal cardiac tamponade [1]. The
PICC should remain in place until venous access is no
longer needed. If it becomes blocked or displaced, it
should not be removed before an attempt at reinsertion. It
is much easier to place a new PICC with one in situ.Tunneled Central Venous CathetersFigure 1. Peripherally inserted central catheters (PICCs) movement depen-
dent on arm position. A 5-month-old patient with urosepsis and bacterial
meningitis, on intravenous antibiotics. (A) A 3F left basilic PICC with the
arm in abduction, demonstrating its tip at the confluence of the brachioce-
phalic veins (arrow). (B) With the arm in adduction, the catheter tip moves
centrally into the mid right atrium (arrow).Tunneled central venous catheters (TCVC) are designed
for intermediate- to long-term regular central venous access,
for example, in the setting of hemodialysis. These catheters
have a subcutaneous tunnel from the point of venous
puncture to the site where the catheter exits the skin. Just
under the skin exit site, the catheter has a circumferential
cuff that allows for the body to incorporate it into the tissue
of the tunnel, which typically takes at least 2 weeks and
reduces the risk of accidental removal, as well as serving as
a physical barrier to infection.
The size of the catheter required depends on patient
size and the intended use for the catheter. Ideally, a 5F
catheter should be used for nondialysis pediatric patients
unless they are of a significant size. Dialysis catheters do
not need to be as large as adult catheters because the flow
rates required are typically less than in the adult setting.
The right internal jugular vein is the preferred venous
access site; however, this choice depends on a variety of
things, including the presence of cardiac anomalies and the
possible future need for arteriovenous fistula formation.
TCVC also can be placed into the femoral, hepatic, renal,
external jugular, subclavian, and thoracic collateral venous
circulation as well as directly into the inferior vena cava
(IVC). Ideally, the tip of a hemodialysis catheter should be
in the right atrium, whereas, an infusion TCVC can have
its tip at the right atrial-caval junction (Figure 2).Implantable Venous Access PortsImplantable ports consist of a central venous catheter
connected to a subcutaneous port. The port consists of
a small reservoir with a firm floor and an anterior septum,
which simplifies safe needle puncture. Because there is no
cutaneous component, ports are best suited to patients who
require intermittent venous access over an extended period of
Figure 2. Central venous catheter placement. A 9-year-old patient with
Goodpasture syndrome, receiving daily plasmapheresis. (A) Initial place-
ment of a tunnelled hemodialysis catheter appears malpositioned, with the
tip appearing at the inferior vena cavaeright atrial junction. (B) Post-
procedure upright posteroanterior chest radiograph confirms that the tip is
optimally positioned within the superior aspect of the right atrium.
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however, they also are useful in patients who require occa-
sional courses of intravenous medication, such as antibiotics
for infections (such as patients with cystic fibrosis) [1]. Ports
are usually placed between the subcutaneous fat and muscle
of the anterior chest wall. They may be placed in the upper
arm in smaller children; however, this puts the overlying skin
at risk for pressure necrosis [6].
Pediatric Angiography and Arterial Intervention
The indications for pediatric angiography and interven-
tion are different for those in adults, both due to the absence
of atherosclerotic disease and the inclusion of congenitaldisorders. Diagnostic angiography has largely been sup-
planted by CT and magnetic resonance angiography except
in certain circumstances in which the resolution of conven-
tional angiography still makes it the criterion standard.
Examples include the workup of renovascular hypertension,
assessment for cerebral vascular pathology (such as vascu-
litis), and mapping of peripheral vessels for limb recon-
struction (Figure 3) [7]. Catheter-based arterial intervention
includes organ and peripheral embolization, angioplasty, and
thrombolysis.
Guidelines that cover pediatric arterial access and arteri-
ography have recently been published, in collaboration, by
the Societies for Interventional Radiology and Pediatric
Radiology [8]. These guidelines cover aspects that include
radiation protection, preprocedure preparation, contrast
media, indications, arterial access, and angiography injection
parameters. Low-osmolar nonionic contrast should be used,
and doses should be limited to 4-5 mL/kg for neonates and
6-8 mL/kg for older children [8]. In neonates, aspirating the
contrast from the dead space of the catheter reduces the
contrast load. Neonates also are at risk of anemia, fluid
overload, and hypothermia from excessive saline solution
flush, which necessitates careful management of all admin-
istered and/or aspirated fluid and blood. A premature neonate
who weighs 1.5 kg has a circulating blood volume of
approximately 147 mL (98 mL/kg at 72 hours of age [9]).
Most invasive arterial procedures are performed by
a common femoral artery puncture. Other access arteries are
occasionally used, including umbilical arteries in neonates.
All arterial punctures should be performed with the patient
under ultrasound guidance. Reducing the access sheath
diameter relative to the artery diameter reduces the risk of
arterial spasm and thrombosis [10]. In cases in which
thrombosis is a significant risk, systemic heparinization
(75-100 IU/kg) is recommended [8]. At the end of the
procedure, hemostasis can be easily achieved with manual
compression. However, care must be taken to avoid arterial
thrombosis due to overcompression, which can best be
achieved by monitoring distal pulses, capillary refill, and
skin colour during compression.Renal Angiography and InterventionThe most common indication for renal angiography is
renovascular hypertension. Up to 25% of pediatric patients
with hypertension have a renovascular cause, the most
common being fibromuscular dysplasia [7]. Renal angiog-
raphy remains the criterion standard because it is able to
identify segmental stenoses, which are often missed on
noninvasive cross-sectional imaging. Occasionally, renal
vein sampling can be used to try and localize the source of
abnormal renin production. Renal artery stenoses, particu-
larly due to fibromuscular dysplasia and neurofibromatosis
type 1, can be treated successfully with angioplasty
(Figure 4). Transplant renal artery stenoses are also very
amenable to angioplasty with stenting as required. A near
100% technical success rate corresponds to a hypertension
Figure 3. Peripheral angiogram. A 13-month-old female patient with autosomal dominant ectrodactyly of the hands and feet. An angiogram was performed to
delineate the small vessels before planned toe transfer to the hand (thereby allowing for a pincer grip). (A) Angiogram of the right hand, showing the dominant
ulnar artery (black arrows) and hypoplastic radial artery; the ulnar artery supplies the digital artery of the single digit (white arrows). (B) Angiogram of the foot,
showing 2 digits with good digital supply to the larger one. (C) Right hand radiograph after digital transfer.
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renal ablation is performed in patients with severe hyper-
tension and a single atrophic kidney (Figure 5).Cerebral Angiography and InterventionDiagnostic cerebral angiography has largely been
replaced by imaging modalities such as CT angiography and
MR angiography. The diagnosis of certain pathologies,
however, necessitates small-vessel assessment, and, at this
time, cerebral angiography often provides the required
resolution in the workup of vasculitis, spinal arteriovenous
(AV) shunts, cerebral aneurysms, and AV malformations
(AVM) in many cases, especially in smaller children
(Figure 6) [12]. In addition, a variety of catheter-based
interventions are now commonplace, including treatment
of vascular lesions, such as aneurysms and AVMs,
preoperative embolization of tumours, functional testing (eg,
Wada test), and treatment of acute ischemic stroke. Pediatric
cerebral angiography is a very low risk procedure, with
stroke being the most feared complication. Postprocedureseizures, transient cortical blindness, or encephalopathy
occur rarely [12].Hepatosplenic Vascular InterventionThere are various indications for hepatic intervention in
the pediatric population. These include embolization of
hepatic vascular malformations and/or tumours, and trau-
matic hemorrhage, treatment of posttransplant hepatic artery
stenosis, chemoembolization of hepatic tumours, and trans-
jugular intrahepatic portosystemic shunt (TIPS) for portal
hypertension.
Liver Transplantation Intervention
Hepatic artery stenosis occurs after liver transplantation at
the arterial anastomosis in up to 20% of patients [13].
Hepatic artery thrombosis occurs in approximately 10%.
Because most stenoses occur within the first 3 months after
transplantation, monitoring with ultrasound is essential to
avoid progression to thrombosis, which can result in
Figure 4. Bilateral renal artery stenosis angioplasty. A 17-year-old female
patient with William syndrome. (A) Abdominal aortography performed via
a left brachial arterial access, demonstrating classic mid aortic stenosis, with
stenosis of the right renal artery origin (white arrow) and with early bifur-
cation, and stenosis at the origin of the left renal artery (black arrow).
(B) Fluoroscopic image showing cutting balloon angioplasty (arrow) of the
right renal artery stenosis.
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stenosis in this setting is best performed by using a trans-
femoral approach. In cases of a borderline stenosis, a pres-
sure gradient greater than 10 mm Hg across the stenosis is an
indication for treatment [14]. Stent deployment should
generally be avoided in the pediatric population and be
reserved for severe recurrent stenoses or angioplasty
complications. Thrombolysis can be attempted in cases of
acute hepatic artery thrombosis. Balloon angioplasty is alsothe treatment of choice for both hepatic and portal venous
stenoses [14].
Hepatic Chemoembolization
Transcatheter arterial chemoembolization (TACE) is
a local therapeutic technique widely used in the treatment of
liver tumours, particularly hepatocellular carcinoma in the
adult population. It uses the fact that hepatic tumours derive
the majority of their blood supply (approximately 95%) from
the hepatic artery, unlike the normal liver, which is supplied
mainly from the portal vein [15]. The chemotherapeutic is
combined with an embolic platform and is injected into the
segmental or lobar hepatic arteries that supply the tumour.
Various embolic platforms exist, including ethiodized oil
such as Lipiodol (Guerbet, Roissy CdG Cedex, France) and
microspheres. In cases in which lipiodol is used, another
embolic is injected after the chemotherapeutic-lipiodol
emulsion to reduce chemotherapeutic washout and
systemic exposure. Although TACE is a palliative technique,
it can downstage the tumour, potentially allowing curative
treatment with liver resection or transplantation [16,17].
In the pediatric population, chemoembolization has been
used successfully to treat primary hepatic malignancies, such
as hepatoblastoma (Figure 7) as well as liver metastases [15].
Cisplatin-Doxorubicin-Lipiodol TACE has been used to
successfully downstage hepatoblastomas, which allowed
resection in 13 of 16 patients in one series [17]. Despite this,
event-free survival remained less than 44% at 5 years,
predominantly due to micrometastases. Similar findings have
been seen elsewhere [18].
TIPS
TIPS is an uncommon procedure used in the treatment of
complications related to portal hypertension that occur in the
setting of end-stage liver disease. Indications for the treat-
ment of portal hypertension with TIPS mirror those of adults
and include life-threatening variceal hemorrhage and
intractable ascites. It can be used as a form of primary
palliation or as an alternative to surgical shunt placement in
patients awaiting liver transplantation. Causes of pediatric
portal hypertension potentially treated with TIPS include
biliary atresia, cystic fibrosis, congenital hepatic fibrosis,
a-1-antitrypsin deficiency, transplant graft rejection, and
viral or autoimmune hepatitis [19].
TIPS involves the endovascular creation of a shunt
between the portal and hepatic veins (Figure 8). This is
performed, as the name suggests, by using a transjugular
approach to cannulate the portal vein from the hepatic vein.
The hepatic tract is then balloon dilated and stented.
Although partially covered stents, such as the Viatorr stents
(WL Gore, Flagstaff, AZ), are used in the adult population,
they can be too large for pediatric patients undergoing TIPS,
which requires placement of covered and uncovered self-
expanding stents. Depending on the stent used, there is
potential for stent dilation as the child grows. The procedure
Figure 5. Renal alcohol ablation. A 2-year-old male patient with severe hypertension and an atrophic congenitally dysplastic left kidney. Dimercaptosuccinic
acid study (not shown) confirmed dominant right-sided renal function (92% vs 8%). (A) Abdominal aortography, showing an enlarged right kidney (black
arrowheads) with 2 renal arteries (white arrows) but a lack of visualization of the left kidney. (B) Selective left renal artery (arrow) angiogram confirms the
known small left kidney, with transarterial alcohol ablation of the left kidney performed through a balloon catheter. (C) Postablation angiogram, showing
truncated renal artery branches (arrows) and no renal parenchymal blush.
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can be used to help cannulate the portal vein. The aim is to
reduce the portosystemic gradient to less than 12 mm Hg.
Reported technical success in children ranges from 78%-
100% [19,20]. Complications include bleeding, hepatic
encephalopathy, shunt stenosis and/or thrombosis, sepsis,
pulmonary oedema, or right heart failure, IVC thrombosis
and death [19]. Due to the smaller size of the pediatric stents
used, regular follow-up with ultrasound is required so that
any signs of stenosis can be treated with early intervention.
Despite this, patency rates up to 81 months have been
reported [21,22].
Splenic EmbolizationSplenomegalySplenic sequestration due to splenomegaly can occur in
patients with portal hypertension, which result in up to 90%
of thrombocytes being removed from the circulation [23].
Other causes of splenomegaly-related thrombocytopenia
include thalassemia major, osteomyelosclerosis, chronicidiopathic thrombocytopenic purpura, and viral infections
such as Epstein Barr virus. Partial splenic embolization
(PSE) is an alternative to surgical splenectomy. It avoids
the risks of overwhelming infection in the setting of total
splenectomy by leaving residual splenic tissue as well as
being a minimal invasive treatment that can be repeated as
necessary.
PSE is an inpatient procedure that involves careful patient
preparation and vigilant postprocedure care. It is recom-
mended that approximately two-thirds of the spleen be
embolized to achieve the desired benefit with respect to
platelet count elevation; however, this results in a significant
ischemic burden with attendant postembolization syndrome
(elevated white blood cell count, fever, and pain). Antibiotic
coverage is essential, and some centres also use pneumo-
coccal, meningococcal, and hemophilus immunization.
Postembolization syndrome with significant abdominal pain
is common, often requiring hospital admission for up to 1-2
weeks [24]. Embolic particles (typically 300-500 mm in
diameter) are administered into the second-order branches of
the splenic artery until near stasis (Figure 9). Some
researchers have suspended the embolic particles in
Figure 6. Moyamoya syndrome. A 6-year-male patient with several episodes
of vertigo and an abnormal electroencephalogram. (A, B) Right internal
cerebral angiograms (anteroposterior and lateral), showing complete occlu-
sion of the internal carotid artery terminus beyond the posterior communi-
cating artery, with the ‘‘puff of smoke’’ collateral pattern consistent with
Moya Moya (arrows).
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provide further antibiotic cover [23,24].
The procedure is technically successful in 100%, with
70% of patients maintaining platelets counts higher than
100,000 per mm3 at 5 years [25]. Thrombocytopenia can
recur in 30% of patients after 1 episode of PSE; however, the
procedure can be successfully repeated. It has been reported
that TIPS does not have any significant effect onhypersplenism and has minimal improvement on platelet
values [21]. However, PSE can reduce portal venous pressure
with the suggestion that this may reduce the risk of variceal
hemorrhage in patients with portal hypertension [23].TraumaSplenic injury is the most common solid abdominal
visceral injury in children [26]. Because the risk of over-
whelming postsplenectomy infection is higher in children
than in adults, splenectomy should be avoided when possible
[27]. Splenic embolization is recognized by surgeons as
a management strategy for the treatment of traumatic pedi-
atric splenic hemorrhage [28]. A hemodynamically stable
patient can be treated conservatively; however, splenic
embolization should be considered in patients who are
unstable or in those requiring ongoing transfusions. Splenic
embolization combined with conservative management can
result in splenic preservation in 97% of patients [26]. The
optimal treatment of splenic artery pseudoaneurysms (SAP)
is uncertain. In the adult population, SAPs are often associ-
ated with delayed rupture; however, this may not be the case
for children, due to the thicker splenic capsule and more
elastic parenchyma [29]. Although researchers have reported
on successful embolization of pediatric SAP, with 76% of
SAP undergoing embolization in one review, there is not
enough good outcome data at present to offer a general
consensus on how these should be managed [29].
The aim of splenic embolization is to treat the focal
hemorrhage or SAP, sparing the rest of the spleen (Figure 10).
It usually is performed with coils; however, other agents,
including liquid adhesive agents (such as n-butyl cyanoac-
rylate) can also be used. Although postembolization pain
from partial splenic infarction is common, other complica-
tions, such as splenic failure and abscess formation, are rare.Arterial Embolization for HemorrhageArterial embolization is a treatment for hemorrhage
commonly performed in the adult population, particularly for
traumatic, gastrointestinal (GI), or pulmonary hemorrhage.
However, although some of the indications are similar in the
pediatric population, there are important differences.
Embolization for GI hemorrhage in pediatric patients is
rare, with few case reports. Upper GI hemorrhage due to
gastritis or peptic ulcers is uncommon compared with the
adult population and has been embolized with varying
degrees of success [30,31]. Other causes of GI hemorrhage,
such as intussusception or Meckel diverticulum, have
a distinct cause that is better treated in a different fashion
than embolization [32]. Technical difficulties related to
pediatric artery size and the need for peripheral embolization
make embolization in young children extremely challenging.
Causes of pediatric pulmonary hemorrhage include
infection, cystic fibrosis, bronchiectasis, tuberculosis,
foreign-body aspiration, and congenital heart disease [33].
Minor hemoptysis is almost always treated conservatively.
Figure 7. Hepatoblastoma and transarterial chemoembolization (TACE). A 15-month-old female patient with rapidly growing hepatoblastoma. (A) Ultrasound
at the time of biopsy, demonstrating a well-defined mass in the right lobe of the liver (arrows). (B) Arterial phase computed tomography (CT) of the enhancing
mass in the liver (arrows). (C) Selective celiac angiogram at the time of TACE, showing the right hepatic artery (black arrow), supplying a dilated tortuous
branch to the hypervascular tumour (black arrowhead), which can be seen to splay the branches of the right hepatic artery (white arrows). (D) Noncontrast CT
post-TACE confirms lipiodol uptake in the tumour (black arrows) as well as trivial lipiodol staining within the adjacent normal liver parenchyma (white arrow).
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every 24 hours, requires more aggressive management [33e35].
Bronchial artery embolization (BAE) should be considered if
bleeding continues despite bronchoscopic treatment. BAE
also is useful in cases of chronic hemoptysis, such as cystic
fibrosis [36].
The bronchial arteries have variable origins but conven-
tionally arise from the anterolateral descending thoracic
aorta at the T5 and T6 levels. There often is recruitment of
systemic arteries to the pulmonary circulation, which also
need to be embolized, if safe to do so. Great care needs to be
taken to identify and avoid embolizing any arteries that
supply the spinal cord. Embolization is typically performed
with 300-500 mm particles. Clinical success occurs in
approximately 90% of pediatric and adult patients with cystic
fibrosis [33,34,37]. However, up to half of these require
further BAE [37]. Apart from chest pain, complications
specific to BAE are rare but include dysphagia, spinal cord
ischemia, aortic necrosis, bronchial necrosis, pulmonary
infarction, and bronchoesophageal fistula.Interventional Treatment of Vascular Malformations
Vascular malformations are subdivided into high- and
low-flow malformations. The classic high-flow vascular
malformation is the AVM, with capillary malformations
occurring much more rarely. Low-flow malformations
include venous, lymphatic, and mixed venolymphatic mal-
formations. Diagnosis is usually made on the basis of clinical
examination combined with imaging. Ultrasound, with
Doppler interrogation, is used to assess many malformations,
especially those situated superficially. Because the clinically
obvious portion of any malformation may represent the ‘‘tip
of the iceberg,’’ cross-sectional imaging (usually magnetic
resonance imaging) is often performed. Low-flow malfor-
mations, such as venous and lymphatic malformations, are
classically hyperintense on T2-weighted imaging and may
have foci of hypointensity within them due to the presence of
phleboliths. AVMs are high-flow lesions and, therefore,
usually hypointense on T2-weighted imaging, with associ-
ated flow voids.
Figure 8. Transjugular intrahepatic portosystemic shunt (TIPS). A 12-year-
old patient with autosomal recessive polycystic kidney disease, renal failure,
and portal hypertension. Portal venography, demonstrating a decompressed
dilated left coronary vein (black arrows) no longer filling uphill esophageal
varices (not shown), patent portal vein (black arrowhead) and TIPS shunt
(white arrowhead), and hepatic vein (white arrow).
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depends onmany factors. At our institution, patientswith these
malformations are reviewed by theVascular AnomaliesClinic,
composed of a multidisciplinary team, including radiology
(including diagnostic and interventional radiologists), plasticFigure 9. Partial splenic embolization for splenomegaly. An 18-year-old patien
arteriogram, showing massive splenomegaly, treated by selectively catheterizing
embolization angiogram, showing pruning of the upper splenic branches (arrowssurgery, dermatology, and other clinical services relevant to the
care of these patients. Individual treatment plans are then
developed, with specificmanagement strategies and long-term
imaging follow-up reviewed on a formal basis at regular
intervals.AVMsAn AVM is an abnormal connection of arteries and veins,
without an intervening capillary bed, which results in
a simple or complex network of connecting vessels called
a nidus (Figure 11). Of AVMs, 40% are detected at birth, and
they occur more often in the pelvis and limbs [38]. Symp-
toms depend on the location and size of the AVM but can
result from pressure effects, bleeding, venous hypertension,
and AV shunting [39].
Interventional treatment of AVMs can be performed
from an arterial, venous, or combined approach. The aim,
to treat the nidus, is the same. Proximal or distal emboli-
zation (ie, non-nidal embolization) results in a higher
incidence of subsequent vascular recruitment and recurrence.
Various embolics can be used, including coils,
liquid adhesive agents, medical-grade alcohol, and Onyx
(Covidien, Irvine, CA). Because many AVMs are complex,
with multiple feeding arteries, draining veins and nidi,
multiple treatments may be required. Staged sessional
treatment can reduce the risk of complications in this setting,
including tissue ischemia and nontarget embolization.t with b-thalassemia and increasing transfusion requirements. (A) Splenic
the upper branches and embolization with 300-500 mm particles. (B) Post-
) with embolization of 60%-80% of the splenic volume.
Figure 10. Splenic embolization for pseudoaneurysm. A 15-year-old male patient who fell onto his left side and presented with severe left upper quadrant pain.
(A) Initial contrast-enhanced computed tomography, showing the splenic rupture (white arrows), with a focal pseudoaneurysm (black arrow). (B) The
pseudoaneurysm was still seen on an ultrasound a few days later (black arrow), associated with the splenic rupture (white arrows). (C) A splenic angiogram
confirmed the presence of the pseudoaneurysm (arrows). (D) It was successfully treated using coil embolization (arrow). This figure is available in colour
online at http://carjonline.org/.
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Although pulmonary AVMs (PAVM) can occur in a non-
syndromic fashion, they are often seen in patients with
hereditary hemorrhagic telangiectasia. PAVMs occur in
a third of patients with hemorrhagic telangiectasia which
itself affects 200 people per million [34]. PAVM can cause
hypoxemia, cerebrovascular ischemia, brain abscesses, and
pulmonary hemorrhage. Cerebrovascular events occur in
approximately 25% of patients with PAVM due to right-to-
left shunting, from pulmonary artery to vein, of venous
emboli without the usual filtering by the pulmonary capillary
bed [40].
PAVMs are usually detected due to their complications;
however, patients with hemorrhagic telangiectasia should bescreened regularly [34]. Pulse oximetry detects any signifi-
cant hypoxemia and CT can then be used to assess the
number and location of any PAVM. The general rule is to
treat any PAVM with a feeding artery of more than 3-mm
diameter. Follow-up CT should be avoided in children,
and, therefore, an exercise stress test with oximetry can be
used to assess for any significant right-to-left shunt.
Embolization of pediatric PAVM is almost always done as
an inpatient procedure with the patient under general anes-
thesia. General anesthesia with intubation enables the
suspension of respiration and thus optimizes imaging. Access
to the pulmonary artery is obtained via the femoral venous
approach. A guide catheter or long sheath can then be used to
allow stable access to the target pulmonary circulation.
Historically, embolization of the feeding arteries of the
Figure 11. Maxillary arteriovenous malformation (AVM) in an 11-year-old
male patient. (A) A computed tomography (CT), showing expansion of the
right maxilla by the AVM nidus (arrows). (B) CT volume reconstruction,
showing the AVM (arrowhead) and dilated drain veins (arrows).
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introduction of Amplatzer vascular plugs (St Jude Medical,
St Paul, MN) can achieve rapid occlusion of a target feeding
artery with a single device (Figure 12) [41]. Complicationsinclude paradoxical embolization of a coil or plug, angina,
transient ischemic attack, and pleurisy. Follow-up is essential
to monitor the growth of any sub-3-mm unoccluded PAVMs.
Vein of Galen Malformation
Vein of Galen malformations are quite rare, accounting
for less than 1% of all cerebral AVMs [42]. Clinical mani-
festations depend upon the degree of AV shunting and
commonly present in the neonate as congestive cardiac
failure, with a mortality without treatment approaching
100% [43]. The diagnosis is sometimes made antenatally on
ultrasound due to hydrocephalus, intracranial hemorrhage, or
cardiomegaly, with fetal hydrops [44]. Embolization is a very
successful procedure that has been shown to result in
a neurologically normal outcome in 74% of treated patients
[45]. The management of Vein of Galen malformations is
extremely challenging and technically demanding. The
decision as to when to treat patients depends on the severity
of symptoms, and there are excellent guidelines in the
literature [45]. The procedure is performed transarterially,
and various embolics, including coils and glue, have been
shown to be effective (Figure 13) [43,45].Venous MalformationsVenous malformations (VM) represent the most common
vascular malformation, with a prevalence of 1% [46]. These
malformations consist of an abnormal network of veins that
have a variable appearance and can focally or diffusely involve
adipose tissue, muscle, and other tissues, often crossing fascial
planes. Approximately 40% occur in the head and neck, with
a similar percentage occurring in the extremities [46]. All are
present from birth, and they tend to grow in proportion to
patient growth. The majority are spontaneous; however, some
are associated with syndromes such as Klippel-Trenaunay,
Maffucci, and blue-rubber bleb nevus [46].
Symptoms typically result from mass effect, local tissue
involvement, venous distension, venous stasis, and, rarely,
hemorrhage. However, in many cases, the primary complaint
is the poor cosmetic appearance of VMs. As with AVMs, it is
important to have a multidisciplinary approach, and a formal
vascular anomalies clinic is ideal. This provides
a surrounding where both the patient’s and their parent’s
expectations can be explored, especially regarding cosmesis.
Many VMs require multiple treatments over years with
palliation of symptoms. Surgical excision is not considered
first-line management. Medical photography provides, in our
opinion, an essential record of treatment.
Percutaneous sclerotherapy is considered first-line treat-
ment for VM and is performed under fluoroscopic and/or
ultrasound guidance. Simple VMs can be treated as outpa-
tient procedures by using sedation. Sclerotherapy with
ethanol can be exceedingly painful and always requires
general anesthesia. Its use should be avoided around nerves.
Due to the risk of hemoglobinuria, adequate hydration is
essential, with larger VMs treated with alcohol. Sodium
Figure 12. Pulmonary arteriovenous malformation (PAVM) embolization. A 4-year-old female patient investigated due to hypoxia. (A, B) A computed
tomography and digital subtraction angiogram (DSA) of large right upper lobe arteriovenous malformation (black arrows), with a large feeding artery (black
arrowheads) and dilated draining vein (white arrows). (C) DSA after embolization, showing the feeding artery (black arrowhead), with no residual PAVM and
multiple coils (black arrows) and a single Amplatzer plug (asterisk).
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can be foamed for easy visualization under ultrasound. Other
sclerosing agents include doxycycline, bleomycin, ethanol-
amine oleate, polidocanol, alcoholic solution of Zein, and
sodium morrhuate [38]. Multiple areas of the VM can be
treated in one sitting; however, care must be taken to avoid
superficial injections, which can result in skin ischemia and
necrosis. Complications after percutaneous sclerotherapy
include skin erythema, necrosis, hyperpigmentation,hemoglobinuria, thrombophlebitis, and thromboembolism
[46,47]. Intravenous ethanol also can cause pulmonary
arterial vasospasm, cardiopulmonary collapse, hyperthermia,
intoxication, and bronchospasm [38].Lymphatic MalformationsLymphatic malformations (LM) consist of an abnormal
collection of dilated lymphatic channels. They present as soft
Figure 13. Embolization of the Vein of Galen malformation. A 6-month-old patient with high output congestive heart failure. (A) Right internal carotid
angiogram, showing marked shunting. (B) An angiogram after coil and glue embolization (arrow), demonstrating greater filling of the middle cerebral artery
due to reduced arteriovenous shunting.
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child. The majority occur in the head and neck region [38].
They can range tremendously in size and may require
treatment due to mass effect, cosmetic appearance, bleeding,
or infection. LMs are subdivided into macrocystic, micro-
cystic, and mixed LMs, and have been called cystic
hygromas and cavernous lymphangiomas, although these
terms are discouraged. Sclerotherapy can be successful at
treating LMs, especially those of the macrocystic variety
(Figure 14) [48].
Sclerotherapy involves aspirating the LM and injecting
a sclerosant such as doxycycline or bleomycin. Another
successful option that does not require complete aspiration isFigure 14. Macrocystic lymphatic malformation (LM). A 14-year-old female
patient with a left supra- and infraclavicular macrocystic LM, seen as
a solitary homogeneous intermediate signal intensity cyst on T1-weighted
magnetic resonance imaging (arrows).OK-432 (Picibanil; Chugai Pharmaceuticals, Tokyo, Japan).
OK-432 is a lyophilized mixture of group A Streptococcus
pyogenes incubated with benyzlpenicillin (Figure 15). It is
thought to work by stimulating the production of cytokines,
which produces a local cellular inflammatory reaction
[38,49]. OK-432 commonly causes fever, inflammation, and
swelling. OK-432 and bleomycin have very similar success
rates for macrocystic lesions, at more than 80%. Bleomycin
also can cause fever. However, a rare but potentially life-
threatening risk associated with bleomycin use is
pulmonary fibrosis [48,49], which requires a rigorous pre-
sclerotherapy assessment, as well as specific dose limits,
both for each session, and for lifetime. Patients undergoing
treatment in the head and neck benefit from admission to
monitor for any airway compromise.
Venous Intervention
Pediatric venous thromboembolism (VTE) is uncommon,
with a diagnosis rate of 4.9 per 100,000 hospital children per
year [50]. VTE is more common in children under the age of
1 year and those 15 years of age and older, especially female
patients. The backbone of treatment for VTE is anti-
coagulation; however, post-thrombotic syndrome can cause
considerable morbidity. Thrombolysis should be considered
in patients with ileofemoral deep venous thrombosis (DVT),
central venous thrombosis, IVC thrombosis, bilateral renal
vein thrombosis, AV fistula graft occlusion, and phlegmasia
cerulea dolens [51,52]. Thrombolysis can be performed
mechanically or, in the absence of contraindications, with the
addition of a thrombolytic, such as alteplase (dosing in the
range of 0.03-0.1 mg/kg/h; maximum of 1-2 mg/h) [51].
There are various thrombectomy devices on the market,
which range from simple infusion catheters to complex
Figure 15. Lymphatic malformation (LM) sclerotherapy. A 1-year-old
female patient with a macrocystic LM that involved the right side of her
neck. (A) Ultrasound (US), demonstrating a multilobulated macrocystic neck
mass (arrows) consistent with LM. (B) US-guided cannulation followed by
the injection of agitated saline solution showed microbubbles throughout the
malformation, which confirmed a single cystic malformation (arrows); 2 mL
of OK-432 was injected as the sclerosant.
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MN) and the Trellis (Bacchus Vascular, Santa Clara, CA).
After the procedure, the patient should be admitted to
a critical care setting to carefully monitor infusion rates and
assess for potential complications. After initial catheter-
directed treatment, an infusion of thrombolytic is often per-
formed, with reassessment venography at 24 hours. If
successful, then any underlying venous stenosis should be
treated, followed by long-term anticoagulation. If there is no
improvement in the appearance of the thrombus at 24 hours,
then it is unlikely that continuing treatment will have any
success. However, with a partial response, thrombolysis can
be continued for 48-72 hours. The most commoncomplication is bleeding, with major bleeding occurring in
15% of cases but with no fatalities [53].
IVC filters have similar indications, regardless of patient
age. These primarily include DVT with a contraindication to
anticoagulation or pulmonary embolism (PE) despite anti-
coagulation [52,54]. More controversial indications include
floating DVT and a high risk of DVT, with contraindication
to anticoagulation, such as patients with polytrauma. IVC
filters have also been placed in the setting of PE prevention
when treating large VMs, where there is risk of thrombo-
embolic complications. Retrievable filters should always be
used with the aim of removing them as soon as possible. The
suitability of IVC filters for young children is uncertain
because there is a minimum IVC size for most filters. There
also are minimal long-term outcome data for pediatric
patients; however, in a small series of 11 patients, there were
no PEs [54]. A Gunther Tulip filter (Cook, Bloomington, IN)
has been placed in 3 young pediatric patients, with the
smallest IVC in a 2-year old patient that measured 5 mm in
diameter [55]. The filter was removed successfully when no
longer needed.Conclusion
There are a wide range of vascular interventional radi-
ology procedures that have either subtle or major variations
when performed in the pediatric population compared with
the adult population. Knowledge of these procedures, the
variations, and the complications are essential for a radiolo-
gist involved in any centre that deals with pediatric patients.
Radiologists can then guide clinicians with regard to the
services interventional radiology can offer their patients.
They also can correctly interpret any complications, reducing
patient morbidity and mortality.References
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